Sat Nov 1 05:10:01 SGT 2014  
HEPATITIS
B
    Hepatitis B, Philippines
Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment 10 days after unprotected sex, detect HIV infection with the DNA test 28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

Hepatitis B, Philippines

Summary

Hepatitis B, Philippines @hepatitisb_biz: Hepatitis B symptoms in men/women, screening/diagnosis, testing/check and treatment, Philippines - Private and confidential service.

Keywords: Hepatitis B Philippines, Philippines Hepatitis B, Hepatitis B.

Description

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
HIV STD TESTING TREATMENT™
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Hepatitis B, Philippines
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Budget airlines based in Singapore:

Budget airlines operating in Singapore:

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute SD Bioline HIV Ag/Ab Combo HIV rapid test:
- Fingerprick blood sampling.
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

Location reference


Latest News

Liver Safety Assessment: Required Data Elements and Best Practices for Data Collection and Standardization in Clinical Trials
Fri, 31 Oct 2014 00:00:51 +0100 | Drug Safety
Abstract

Liver Safety Assessment in Special Populations (Hepatitis B, C, and Oncology Trials)
Fri, 31 Oct 2014 00:00:46 +0100 | Drug Safety
Abstract

Single‐nucleotide substitution of Hepatitis B virus in intrauterine infection
Thu, 30 Oct 2014 05:57:18 +0100 | Journal of Viral Hepatitis
Summary

Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus‐infected patients
Wed, 29 Oct 2014 00:00:00 +0100 | Hepatology
Conclusion: We found that while only a small number of HCV patients were coinfected with HBV, patients with documented HBV viremia were at a significantly higher risk for cirrhosis, HCC, and overall death than HCV monoinfected patients. Absence of HBV replication was associated with a clinical course similar to that of HCV monoinfected patients. (Hepatology 2014) (Source: Hepatology)

Use of Tenofovir Disoproxil Fumarate in Highly Viremic, Hepatitis B Mono-Infected Pregnant Women
Tue, 28 Oct 2014 15:09:28 +0100 | Digestive Diseases and Sciences
Conclusions

Adding peginterferon to entecavir for HBeAg‐positive chronic hepatitis B: A multicentre randomized trial (ARES study)
Tue, 28 Oct 2014 00:00:00 +0100 | Hepatology
Conclusion: Although the primary endpoint was not reached, 24 weeks of PEG‐IFN add‐on therapy led to a higher proportion of HBeAg response compared to ETV monotherapy. Add‐on therapy resulted in more viral decline and appeared to prevent relapse after stopping ETV. Hence PEG‐IFN add‐on therapy may facilitate the discontinuation of nucleos(t)ide analogues. http://www.Clinicaltrials.gov number: NCT00877760. (Hepatology 2014;) (Source: Hepatology)

Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in HCV but not HBV infection
Tue, 28 Oct 2014 00:00:00 +0100 | Hepatology
Conclusion: Our study demonstrates a tight interaction between variations in serum sphingolipid levels and progression of liver fibrosis as well as responsiveness to antiviral therapy. Particularly sphingosine, sphinganine and C24ceramide appear as promising novel biomarkers in chronic HCV infection and should be further evaluated within the non‐invasive prediction of liver fibrosis. (Hepatology 2014;) (Source: Hepatology)

A Randomized, Three‐arm Study to Optimize Lamivudine Efficacy in HBeAg Positive Chronic Hepatitis B Patients
Tue, 28 Oct 2014 00:00:00 +0100 | Journal of Gastroenterology and Hepatology
ConclusionsCombination therapy of lamivudine plus ADV exhibited effective viral suppression and relatively low resistance in HBeAg positive CHB patients. In lamivudine treated patients with suboptimal virological response at week 24, promptly adding on ADV is necessary to prevent resistance development. (Source: Journal of Gastroenterology and Hepatology)

Clinical Events after Cessation of Lamivudine Therapy in Patients Recovered from a Hepatitis B Flare with Hepatic Decompensation
Tue, 28 Oct 2014 00:00:00 +0100 | Clinical Gastroenterology and Hepatology
& Aims: Before guidelines were issued, instead of indefinite therapy, many patients with hepatitis B flare and hepatic decompensation had discontinued lamivudine therapy. We investigated heir outcomes. (Source: Clinical Gastroenterology and Hepatology)

Adverse Effects of Vitamin D Deficiency on Outcomes of Patients with Chronic Hepatitis B
Tue, 28 Oct 2014 00:00:00 +0100 | Clinical Gastroenterology and Hepatology
& Aims: Vitamin D is an immune modulator that might be involved in the pathogenesis of viral hepatitis. We investigated the effects of vitamin D deficiency on long-term outcomes of patients with chronic hepatitis B (CHB). (Source: Clinical Gastroenterology and Hepatology)